JC Chemical Co., Ltd. (KOSDAQ:137950)
South Korea · Delayed Price · Currency is KRW 2,940.00
+10.00 (0.34%)
At close: Jun 10, 2026
JC Chemical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 410,397 | 367,542 | 367,320 | 439,247 | 511,666 | 392,923 |
Other Revenue | -0 | -0 | - | - | -0 | -0 |
| 410,397 | 367,542 | 367,320 | 439,247 | 511,666 | 392,923 | |
Revenue Growth (YoY) | 14.15% | 0.06% | -16.38% | -14.15% | 30.22% | 46.78% |
Cost of Revenue | 383,622 | 340,316 | 337,011 | 387,798 | 452,689 | 339,599 |
Gross Profit | 26,775 | 27,226 | 30,309 | 51,449 | 58,977 | 53,324 |
Selling, General & Admin | 17,343 | 16,944 | 17,306 | 16,971 | 14,822 | 12,321 |
Amortization of Goodwill & Intangibles | 269.09 | 267.35 | 207.83 | 101.38 | 168.44 | 168.44 |
Other Operating Expenses | 131.1 | 133.64 | 54.8 | 29 | 36.16 | 19.57 |
Operating Expenses | 19,765 | 19,508 | 19,619 | 19,352 | 16,328 | 13,547 |
Operating Income | 7,010 | 7,718 | 10,690 | 32,097 | 42,649 | 39,777 |
Interest Expense | -9,487 | -9,314 | -8,342 | -5,481 | -4,886 | -3,353 |
Interest & Investment Income | 1,903 | 1,939 | 1,938 | 1,537 | 719.56 | 465.46 |
Earnings From Equity Investments | 157.71 | 174.86 | -174.86 | -80.76 | -138.74 | -70.5 |
Currency Exchange Gain (Loss) | -156.69 | -5,260 | 4,538 | 1,315 | -9,675 | 3,185 |
Other Non Operating Income (Expenses) | 409.65 | 835.4 | 905.72 | 775.27 | 904.71 | 834.41 |
EBT Excluding Unusual Items | -163.07 | -3,906 | 9,554 | 30,162 | 29,574 | 40,838 |
Gain (Loss) on Sale of Investments | 290 | 292.04 | 8.6 | -15.37 | -210.89 | -10.82 |
Gain (Loss) on Sale of Assets | -111.07 | -117.63 | -16.65 | -1.92 | -346.04 | 31.53 |
Asset Writedown | 20.94 | 20.94 | -104.27 | -34.44 | 1.08 | - |
Pretax Income | 36.8 | -3,710 | 9,442 | 30,111 | 29,018 | 40,859 |
Income Tax Expense | 869.25 | 1,442 | 3,795 | 8,986 | 9,831 | 7,487 |
Earnings From Continuing Operations | -832.45 | -5,152 | 5,647 | 21,125 | 19,187 | 33,372 |
Minority Interest in Earnings | 501.03 | 1,196 | 423.73 | -353.03 | 1,213 | -609.32 |
Net Income | -331.42 | -3,956 | 6,071 | 20,772 | 20,399 | 32,763 |
Net Income to Common | -331.42 | -3,956 | 6,071 | 20,772 | 20,399 | 32,763 |
Net Income Growth | - | - | -70.78% | 1.83% | -37.74% | 318.37% |
Shares Outstanding (Basic) | 22 | 22 | 22 | 22 | 22 | 22 |
Shares Outstanding (Diluted) | 22 | 22 | 22 | 22 | 22 | 22 |
Shares Change (YoY) | -0.10% | -1.15% | -0.57% | - | - | 0.11% |
EPS (Basic) | -15.37 | -183.29 | 278.00 | 945.81 | 928.82 | 1491.76 |
EPS (Diluted) | -15.37 | -183.29 | 278.00 | 945.81 | 928.82 | 1491.76 |
EPS Growth | - | - | -70.61% | 1.83% | -37.74% | 317.92% |
Free Cash Flow | -27,356 | -53,587 | -11,540 | 38,151 | 14,375 | -14,748 |
Free Cash Flow Per Share | -1268.71 | -2482.50 | -528.45 | 1737.09 | 654.54 | -671.52 |
Dividend Per Share | - | - | - | 150.000 | 160.000 | 150.000 |
Dividend Growth | - | - | - | -6.25% | 6.67% | 66.67% |
Gross Margin | 6.52% | 7.41% | 8.25% | 11.71% | 11.53% | 13.57% |
Operating Margin | 1.71% | 2.10% | 2.91% | 7.31% | 8.33% | 10.12% |
Profit Margin | -0.08% | -1.08% | 1.65% | 4.73% | 3.99% | 8.34% |
Free Cash Flow Margin | -6.67% | -14.58% | -3.14% | 8.69% | 2.81% | -3.75% |
EBITDA | 21,381 | 21,644 | 22,475 | 43,973 | 53,335 | 49,028 |
EBITDA Margin | 5.21% | 5.89% | 6.12% | 10.01% | 10.42% | 12.48% |
D&A For EBITDA | 14,371 | 13,926 | 11,786 | 11,876 | 10,686 | 9,251 |
EBIT | 7,010 | 7,718 | 10,690 | 32,097 | 42,649 | 39,777 |
EBIT Margin | 1.71% | 2.10% | 2.91% | 7.31% | 8.33% | 10.12% |
Effective Tax Rate | 2361.97% | - | 40.19% | 29.84% | 33.88% | 18.32% |